Skip to main content
OpenTrials
Completed

NCT Number: NCT02897882

Acute and Chronic Pain in Lung Transplantation: Prevalence, Associated Factors, Taken Care

The objective of this project is to estimate the frequency and the characters of the chronic pains by a follow-up which begins during the registration on the waiting list of transplant and which ends at the end of the third year following the lung transplantation. It is a forward-looking study of prevalence entering within the framework of the common care. After lung transplant, pain will be evaluate with questionnaires every day during the hospitalisation, and then after 1 month, 3 months, 6 months, 1 year, 2 years and 3 years.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hopital Foch

Suresnes, 92150, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients benefiting from a lung transplant
  • Patients on a list for a lung transplant from may 2010

Exclusion criteria

  • Patients refusing to participate in the study

Treatment and study plan

Lung transplant

Other

Pain evaluation

Primary outcomes

  1. Chronic pain measured by a digital scale

    Time frame: 3 years

Sponsors and collaborators

Lead sponsor

Hopital Foch

Other

Registry information

Official study title

Acute and Chronic Pain in Lung Transplantation: Prevalence, Associated Factors, Medical Care

Acronym: MUCODOULEUR

Important dates

Study start
2010
Primary completion
2017
Study completion
2017
First posted
Sep 13, 2016
Registry last updated
May 22, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.